{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:25:55Z","timestamp":1783488355992,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T00:00:00Z","timestamp":1577664000000},"content-version":"vor","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81802596"],"award-info":[{"award-number":["No.81802596"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010229","name":"Natural Science Foundation of Tianjin Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["17ZR1403500"],"award-info":[{"award-number":["17ZR1403500"]}],"id":[{"id":"10.13039\/501100010229","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Sailing Program","award":["16YF1401100"],"award-info":[{"award-number":["16YF1401100"]}]},{"name":"Shanghai Sailing Program","award":["19YF1404300"],"award-info":[{"award-number":["19YF1404300"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The clinical significance of hematogenous and lymphatic metastasis in ovarian cancer has been increasingly addressed, as it plays an imperative role in the formation of both intraperitoneal and distant metastases. Our objective is to identify the key molecules and biological processes potentially related to this relatively novel metastatic route in serous ovarian cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Since lymphovascular space invasion (LVSI) is considered as the first step of hematogenous and lymphatic dissemination, we developed a gene signature mainly based on the transcriptome profiles with available information on LVSI status in the Cancer Genome Atlas (TCGA) dataset. We then explored the underlying biological rationale and prognostic value of the identified gene signature using multiple public databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We observe that primary tumors with increased risk of hematogenous and lymphatic metastasis highly express a panel of genes, namely POSTN, LUM, THBS2, COL3A1, COL5A1, COL5A2, FAP1 and FBN1. The identified geneset is characterized by enhanced deposition of extracellular matrix and extensive stromal activation. Mechanistically, both the recruitment and the activation of stromal cells, especially fibroblasts, are closely associated with lymphovascular metastasis. Survival analysis further reveals that the elevated expression of the identified genes correlates to cancer progression and poor prognosis in patients with serous ovarian cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings indicate that tumor stroma supports the hematogenous and lymphatic spread of ovarian cancer, increasing tumor invasiveness and ultimately resulting in worse survival. Thus stroma-targeted therapies may improve the clinical outcomes in combination with cytoreductive surgery and chemotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-019-6470-y","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T16:02:21Z","timestamp":1577721741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Huiran","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoman","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4525-8278","authenticated-orcid":false,"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,30]]},"reference":[{"key":"6470_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ijgo.12614","volume":"143","author":"JS Berek","year":"2018","unstructured":"Berek JS, Kehoe ST, Kumar L, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum. Int J Gynecol Obstet. 2018;143:59\u201378.","journal-title":"Int J Gynecol Obstet"},{"issue":"11","key":"6470_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3390\/cancers10110444","volume":"10","author":"Maria Barbolina","year":"2018","unstructured":"Barbolina MV.\u00a0Molecular Mechanisms Regulating Organ-Specific Metastases in Epithelial Ovarian Carcinoma.\u00a0Cancers (Basel). 2018;10(11):444.","journal-title":"Cancers"},{"issue":"6","key":"6470_CR3","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/cncr.22919","volume":"110","author":"U Guth","year":"2007","unstructured":"Guth U, Huang DJ, Bauer G, Stieger M, Wight E, Singer G. Metastatic patterns at autopsy in patients with ovarian carcinoma. Cancer. 2007;110(6):1272\u201380.","journal-title":"Cancer"},{"issue":"12","key":"6470_CR4","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.ejso.2016.05.010","volume":"42","author":"C Van Berckelaer","year":"2016","unstructured":"Van Berckelaer C, Brouwers AJ, Peeters DJ, Tjalma W, Trinh XB, van Dam PA. Current and future role of circulating tumor cells in patients with epithelial ovarian cancer. Eur J Surg Oncol. 2016;42(12):1772\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"15","key":"6470_CR5","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.7150\/jca.15644","volume":"7","author":"C Bachmann","year":"2016","unstructured":"Bachmann C, Bachmann R, Fend F, Wallwiener D. Incidence and impact of lymph node metastases in advanced ovarian Cancer: implications for surgical treatment. J Cancer. 2016;7(15):2241\u20136.","journal-title":"J Cancer"},{"issue":"2","key":"6470_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/cam4.31","volume":"1","author":"K Matsuo","year":"2012","unstructured":"Matsuo K, Sheridan TB, Yoshino K, Miyake T, Hew KE, Im DD, et al. Significance of lymphovascular space invasion in epithelial ovarian cancer. Cancer Med. 2012;1(2):156\u201364.","journal-title":"Cancer Med"},{"issue":"6","key":"6470_CR7","doi-asserted-by":"crossref","first-page":"9672","DOI":"10.18632\/oncotarget.14192","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Li S, Chen R, Lu X. Increased risk of poor survival in ovarian cancer patients with high expression of SNAI2 and lymphovascular space invasion. Oncotarget. 2017;8(6):9672\u201385.","journal-title":"Oncotarget"},{"issue":"1","key":"6470_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","volume":"26","author":"S Pradeep","year":"2014","unstructured":"Pradeep S, Kim SW, Wu SY, Nishimura M, Chaluvally-Raghavan P, Miyake T, et al. Hematogenous metastasis of ovarian cancer: rethinking mode of spread. Cancer Cell. 2014;26(1):77\u201391.","journal-title":"Cancer Cell"},{"key":"6470_CR9","doi-asserted-by":"publisher","first-page":"bat013","DOI":"10.1093\/database\/bat013","volume":"2013","author":"BF Ganzfried","year":"2013","unstructured":"Ganzfried BF, Riester M, Haibe-Kains B, Risch T, Tyekucheva S, Jazic I, et al. curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome. Database (Oxford). 2013;2013:bat013.","journal-title":"Database (Oxford)"},{"issue":"5","key":"6470_CR10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284\u20137.","journal-title":"Omics"},{"key":"6470_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"6470_CR12","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"5","key":"6470_CR13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol. 2012;30(5):413\u201321.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"6470_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218.","journal-title":"Genome Biol"},{"issue":"21","key":"6470_CR15","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108\u201310.","journal-title":"Cancer Res"},{"issue":"3","key":"6470_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/bjc.2017.458","volume":"118","author":"AE Yuzhalin","year":"2018","unstructured":"Yuzhalin AE, Urbonas T, Silva MA, Muschel RJ, Gordon-Weeks AN. A core matrisome gene signature predicts cancer outcome. Br J Cancer. 2018;118(3):435\u201340.","journal-title":"Br J Cancer"},{"issue":"16","key":"6470_CR17","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","volume":"14","author":"RW Tothill","year":"2008","unstructured":"Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res. 2008;14(16):5198\u2013208.","journal-title":"Clin Cancer Res"},{"key":"6470_CR18","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network.\u00a0Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609\u201315.","DOI":"10.1038\/nature10166"},{"issue":"5","key":"6470_CR19","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6(5):392\u2013401.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"6470_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ccr.2012.08.013","volume":"22","author":"A Calon","year":"2012","unstructured":"Calon A, Espinet E, Palomo-Ponce S, Tauriello DV, Iglesias M, Cespedes MV, et al. Dependency of colorectal cancer on a TGF-beta-driven program in stromal cells for metastasis initiation. Cancer Cell. 2012;22(5):571\u201384.","journal-title":"Cancer Cell"},{"issue":"1","key":"6470_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/carcin\/bgr230","volume":"33","author":"J Cai","year":"2012","unstructured":"Cai J, Tang H, Xu L, Wang X, Yang C, Ruan S, et al. Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness. Carcinogenesis. 2012;33(1):20\u20139.","journal-title":"Carcinogenesis"},{"key":"6470_CR22","doi-asserted-by":"publisher","first-page":"e915","DOI":"10.1038\/cddis.2013.442","volume":"4","author":"RY Huang","year":"2013","unstructured":"Huang RY, Wong MK, Tan TZ, Kuay KT, Ng AH, Chung VY, et al. An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis. 2013;4:e915.","journal-title":"Cell Death Dis"},{"key":"6470_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.trsl.2016.03.016","volume":"175","author":"LG Coffman","year":"2016","unstructured":"Coffman LG, Burgos-Ojeda D, Wu R, Cho K, Bai S, Buckanovich RJ. New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination. Transl Res. 2016;175:92\u2013102.e102.","journal-title":"Transl Res"},{"issue":"3","key":"6470_CR24","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ygyno.2018.06.022","volume":"150","author":"K Deng","year":"2018","unstructured":"Deng K, Yang C, Tan Q, Song W, Lu M, Zhao W, et al. Sites of distant metastases and overall survival in ovarian cancer: a study of 1481 patients. Gynecol Oncol. 2018;150(3):460\u20135.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"6470_CR25","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1158\/1535-7163.MCT-17-0643","volume":"17","author":"A Figueras","year":"2018","unstructured":"Figueras A, Alsina-Sanchis E, Lahiguera A, Abreu M, Muinelo-Romay L, Moreno-Bueno G, et al. A role for CXCR4 in peritoneal and Hematogenous ovarian Cancer dissemination. Mol Cancer Ther. 2018;17(2):532\u201343.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"6470_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ygyno.2015.08.026","volume":"139","author":"Z Liu","year":"2015","unstructured":"Liu Z, Beach JA, Agadjanian H, Jia D, Aspuria PJ, Karlan BY, et al. Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation. Gynecol Oncol. 2015;139(3):394\u2013400.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"6470_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1158\/1078-0432.CCR-13-1256","volume":"20","author":"DJ Cheon","year":"2014","unstructured":"Cheon DJ, Tong Y, Sim MS, Dering J, Berel D, Cui X, et al. A collagen-remodeling gene signature regulated by TGF-beta signaling is associated with metastasis and poor survival in serous ovarian cancer. Clin Cancer Res. 2014;20(3):711\u201323.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"6470_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.molmed.2013.05.004","volume":"19","author":"S Madar","year":"2013","unstructured":"Madar S, Goldstein I, Rotter V. 'Cancer associated fibroblasts'--more than meets the eye. Trends Mol Med. 2013;19(8):447\u201353.","journal-title":"Trends Mol Med"},{"issue":"11","key":"6470_CR29","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/cancers10110406","volume":"10","author":"Subramanyam Dasari","year":"2018","unstructured":"Dasari S, Fang Y, Mitra AK.\u00a0Cancer Associated Fibroblasts: Naughty Neighbors That Drive Ovarian Cancer Progression.\u00a0Cancers (Basel). 2018;10(11):406.","journal-title":"Cancers"},{"issue":"6","key":"6470_CR30","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41571-018-0007-1","volume":"15","author":"KC Valkenburg","year":"2018","unstructured":"Valkenburg KC, de Groot AE, Pienta KJ. Targeting the tumour stroma to improve cancer therapy. Nat Rev Clin Oncol. 2018;15(6):366\u201381.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"6470_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cmet.2018.08.007","volume":"29","author":"M Curtis","year":"2019","unstructured":"Curtis M, Kenny HA, Ashcroft B, Mukherjee A, Johnson A, Zhang Y, et al. Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis. Cell Metab. 2019;29(1):141\u2013155.e149.","journal-title":"Cell Metab"},{"issue":"10","key":"6470_CR32","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1172\/JCI62229","volume":"122","author":"SY Ko","year":"2012","unstructured":"Ko SY, Barengo N, Ladanyi A, Lee JS, Marini F, Lengyel E, et al. HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts. J Clin Invest. 2012;122(10):3603\u201317.","journal-title":"J Clin Invest"},{"issue":"8","key":"6470_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc.2017.51","volume":"17","author":"M De Palma","year":"2017","unstructured":"De Palma M, Biziato D, Petrova TV. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer. 2017;17(8):457\u201374.","journal-title":"Nat Rev Cancer"},{"key":"6470_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2017.11.026","volume":"415","author":"Z Yang","year":"2018","unstructured":"Yang Z, Jin P, Xu S, Zhang T, Yang X, Li X, et al. Dicer reprograms stromal fibroblasts to a pro-inflammatory and tumor-promoting phenotype in ovarian cancer. Cancer Lett. 2018;415:20\u20139.","journal-title":"Cancer Lett"},{"issue":"40","key":"6470_CR35","doi-asserted-by":"crossref","first-page":"67315","DOI":"10.18632\/oncotarget.18621","volume":"8","author":"R Wei","year":"2017","unstructured":"Wei R, Lv M, Li F, Cheng T, Zhang Z, Jiang G, et al. Human CAFs promote lymphangiogenesis in ovarian cancer via the Hh-VEGF-C signaling axis. Oncotarget. 2017;8(40):67315\u201328.","journal-title":"Oncotarget."},{"issue":"1","key":"6470_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.canlet.2011.01.011","volume":"303","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Tang H, Cai J, Zhang T, Guo J, Feng D, et al. Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion. Cancer Lett. 2011;303(1):47\u201355.","journal-title":"Cancer Lett"},{"issue":"4","key":"6470_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41419-019-1435-2","volume":"10","author":"R Zhang","year":"2019","unstructured":"Zhang R, Qi F, Zhao F, Li G, Shao S, Zhang X, et al. Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer. Cell Death Dis. 2019;10(4):273.","journal-title":"Cell Death Dis"},{"issue":"5","key":"6470_CR38","first-page":"1639","volume":"9","author":"AM Scott","year":"2003","unstructured":"Scott AM, Wiseman G, Welt S, Adjei A, Lee FT, Hopkins W, et al. A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res. 2003;9(5):1639\u201347.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"6470_CR39","first-page":"44","volume":"26","author":"RD Hofheinz","year":"2003","unstructured":"Hofheinz RD, al-Batran SE, Hartmann F, Hartung G, Jager D, Renner C, et al. Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer. Onkologie. 2003;26(1):44\u20138.","journal-title":"Onkologie"},{"issue":"16","key":"6470_CR40","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1158\/0008-5472.CAN-13-0023","volume":"73","author":"TL Yeung","year":"2013","unstructured":"Yeung TL, Leung CS, Wong KK, Samimi G, Thompson MS, Liu J, et al. TGF-beta modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. Cancer Res. 2013;73(16):5016\u201328.","journal-title":"Cancer Res"},{"issue":"3","key":"6470_CR41","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/jnci\/djy097","volume":"111","author":"TL Yeung","year":"2019","unstructured":"Yeung TL, Sheng J, Leung CS, Li F, Kim J, Ho SY, et al. Systematic identification of Druggable epithelial-stromal crosstalk signaling networks in ovarian Cancer. J Natl Cancer Inst. 2019;111(3):272\u201382.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"6470_CR42","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","volume":"3","author":"S Colak","year":"2017","unstructured":"Colak S, Ten Dijke P. Targeting TGF-beta signaling in Cancer. Trends Cancer. 2017;3(1):56\u201371.","journal-title":"Trends Cancer"},{"issue":"2","key":"6470_CR43","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ygyno.2013.12.021","volume":"132","author":"BY Karlan","year":"2014","unstructured":"Karlan BY, Dering J, Walsh C, Orsulic S, Lester J, Anderson LA, et al. POSTN\/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer. Gynecol Oncol. 2014;132(2):334\u201342.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"6470_CR44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nm.1908","volume":"15","author":"P Farmer","year":"2009","unstructured":"Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Becette V, et al. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med. 2009;15(1):68\u201374.","journal-title":"Nat Med"},{"key":"6470_CR45","first-page":"51","volume":"3","author":"H Kim","year":"2010","unstructured":"Kim H, Watkinson J, Varadan V, Anastassiou D. Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Med Genet. 2010;3:51.","journal-title":"BMC Med Genet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6470-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6470-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6470-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T19:24:00Z","timestamp":1609183440000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6470-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6470"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6470-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.15974\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.15974\/v2","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"1 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All data were obtained from public databases, with ethics approval by the corresponding institutes.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1266"}}